Vitenskapelig artikkel

• Heidi Grundt; Dennis W.T. Nilsen; O Hetland et al. (2004). Activated factor 12 (FXIIa) predicts recurrent coronary events after an acute myocardial infarction. (ekstern lenke)
• Renske H Olie; P van der Meijden; Henk MH Spronk et al. (2019). Effects of the PAR-1 Antagonist Vorapaxar on Platelet Activation and Coagulation Biomarkers in Patients with Stable Coronary Artery Disease. (ekstern lenke)
• Leik Woie; Trygve Eftestøl; Kjersti Engan et al. (2011). The heart rate of ventricular tachycardia following an old myocardial infarction is inversely related to the size of scarring. (ekstern lenke)
• Hall Schartum-Hansen; Kjetil Halvorsen Løland; Gard Frodahl Tveitevåg Svingen et al. (2015). Use of loop diuretics is associated with increased mortality in patients with suspected coronary artery disease, but without systolic heart failure or renal impairment: an observational study using propensity score matching. (ekstern lenke)
• Gard Frodahl Tveitevåg Svingen; Hall Schartum-Hansen; Per Magne Ueland et al. (2014). Elevated plasma dimethylglycine is a risk marker of mortality in patients with coronary heart disease. (ekstern lenke)
• Hogne Sønnesyn; Dennis W.T. Nilsen; Ketil Oppedal et al. (2012). Relationship between orthostatic hypotension and white matter hyperintensity load in older patients with mild dementia. (ekstern lenke)
• Mads Malm Svenningsson; Gard Frodahl Tveitevåg Svingen; Vegard Lysne et al. (2020). Transsulfuration metabolites and the association with incident atrial fibrillation – An observational cohort study among Norwegian patients with stable angina pectoris. (ekstern lenke)
• T. Omland; V. V. S. Bonarjee; Dennis W.T. Nilsen et al. (1993). Prognostic significance of N-terminal pro-atrial natriuretic factor (1-98) in acute myocardial infarction: Comparison with atrial natriuretic factor (99-126) and clinical evaluation. (ekstern lenke)
• Elin Strand; Eva Kristine Ringdal Pedersen; Gard Frodahl Tveitevåg Svingen et al. (2013). Dietary intake of n-3 long-chain polyunsaturated fatty acids and risk of myocardial infarction in coronary artery disease patients with or without diabetes mellitus: a prospective cohort study. (ekstern lenke)
• Ricardo León de la Fuente; Patrycja Næsgaard; Stein Tore Nilsen et al. (2013). Omega-3 index and prognosis in acute coronary chest pain patients with a low dietary intake of omega-3. (ekstern lenke)
• Kaare Bønaa; Jan Torbjørn Mannsverk; Rune Wiseth et al. (2016). Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease. (ekstern lenke)
• Reidun Aarsetøy; Thor Ueland; Pål Aukrust et al. (2021). Complement component 7 is associated with total- and cardiac death in chest-pain patients with suspected acute coronary syndrome. (ekstern lenke)
• Patrycja Næsgaard; Ricardo Leon de la Fuente; Stein Tore Nilsen et al. (2012). Serum 25(OH)D is a 2-year predictor of all-cause mortality, cardiac death and sudden cardiac death in chest pain patients from Northern Argentina. (ekstern lenke)
• Reidun Aarsetøy; Hugo ten Cate; Henri Spronk et al. (2021). Activated factor XI-antithrombin complex presenting as an independent predictor of 30-days mortality in out-of-hospital cardiac arrest patients. (ekstern lenke)
• Tor Melberg; Jan Erik Nordrehaug; Dennis W.T. Nilsen (2010). A comparison of the health status after percutaneous coronary intervention at a hospital with and without on-site cardiac surgical backup: a randomized trial in nonemergent patients. (ekstern lenke)
• Trygve Brügger-Andersen; Leif Bostad; Dagny Ann Sandnes et al. (2010). The activity of pregnancy-associated plasma protein A (PAPP-A) as expressed by immunohistochemistry in atherothrombotic plaques obtained by aspiration thrombectomy in patients presenting with a ST-elevation myocardial infarction: a brief communication. (ekstern lenke)
• Dennis W.T. Nilsen; Tor Melberg; Alf Inge Larsen et al. (2006). Late complications following the deployment of drug eluting stents. (ekstern lenke)
• Dennis W.t. Nilsen; Jan Erik Nordrehaug (2001). Nytt PTCA-senter i Helseregion III. (ekstern lenke)
• Trygve Eftestøl; Leik Woie; Kjersti Engan et al. (2012). Texture Analysis to Assess Risk of Serious Arrhythmias after Myocardial Infarction. (ekstern lenke)
• Ricardo Leon de la Fuente; Patrycja Næsgaard; Stein Tore Nilsen et al. (2011). B-type natriuretic peptide and high sensitive C-reactive protein predict 2-year all cause mortality in chest pain patients: a prospective observational study from Salta, Argentina. (ekstern lenke)
• Hogne Sønnesyn; Dennis W.T. Nilsen; Arvid Rongve et al. (2009). High Prevalence of Orthostatic Hypotension in Mild Dementia. (ekstern lenke)
• Dennis W.T. Nilsen; Hildegunn Aarsetøy; Volker Pønitz et al. (2017). The prognostic utility of dihomo-gamma-linolenic acid (DGLA) in patients with acute coronary heart disease.. (ekstern lenke)
• Alf Inge Larsen; Dennis W.T. Nilsen (2005). Persistent left superior vena cava. Use of an innominate vein between left and right superior caval veins for the placement of a right ventricular lead during ICD/CRT implantation. (ekstern lenke)
• Arve Ulvik; Marta Ebbing; Steinar Hustad et al. (2010). Long- and short-term effects of tobacco smoking on circulating concentrations of B vitamins. (ekstern lenke)
• Trygve Brügger-Andersen; Volker Pönitz; Harry Staines et al. (2008). B-type natriuretic peptide is a long-term predictor of all-cause mortality, whereas high-sensitive C-reactive protein predicts recurrent short-term troponin T positive cardiac events in chest pain patients: a prognostic study. (ekstern lenke)
• Marc P. Bonaca; Benjamin M. Scirica; Eugene Braunwald et al. (2014). New ischemic stroke and outcomes with vorapaxar versus placebo: Results from the TRA 2°P-TIMI 50 trial. (ekstern lenke)
• Dennis W.T. Nilsen; Peder Langeland Myhre; Are Kalstad et al. (2021). Serum levels of dihomo-gamma (γ)-linolenic acid (dgla) are inversely associated with linoleic acid and total death in elderly patients with a recent myocardial infarction. (ekstern lenke)
• Hui Zuo; Ottar Nygård; Per Magne Ueland et al. (2018). Association of plasma neopterin with risk of an inpatient hospital diagnosis of atrial fibrillation: results from two prospective cohort studies. (ekstern lenke)
• H Grundt; DWT Nilsen; MA Mansoor et al. (2003). Increased lipid peroxidation during long-term intervention with high doses of n-3 fatty acids (PUFAs) following an acute myocardial infarction. (ekstern lenke)
• Trygve Brügger-Andersen; Øyvind Hetland; Volker Pönitz et al. (2007). The effect of primary percutaneous coronary intervention as compared to tenecteplase on myeloperoxidase, pregnancy-associated plasma protein A, soluble fibrin and D-dimer in acute myocardial infarction. (ekstern lenke)
• Mari Skar Manger; Elin Strand; Marta Ebbing et al. (2010). Dietary intake of n-3 long-chain polyunsaturated fatty acids and coronary events in Norwegian patients with coronary artery disease. (ekstern lenke)
• Volker Pönitz; Trygve Brügger-Andersen; David Pritchard et al. (2009). Activated factor XII type A predicts long-term mortality in patients admitted with chest pain. (ekstern lenke)
• Gregg W. Stone; Bernard Witzenbichler; Giulio Guagliumi et al. (2008). Bivalirudin during primary PCI in acute myocardial infarction. (ekstern lenke)
• Dennis WT Nilsen; Reidun Aarsetøy; Volker Pønitz et al. (2025). Sex-related differences in the prognostic utility of inflammatory and thrombotic cardiovascular risk markers in patients with chest pain of suspected coronary origin. (ekstern lenke)
• Are Kalstad; Peder Langeland Myhre; Kristian Laake et al. (2020). Effects of n-3 fatty acid supplementations in elderly patients after myocardial infarction: A randomized controlled trial. (ekstern lenke)
• D. W. T. Nilsen; G. Albrektsen; Knud Holck Landmark et al. (2001). Effects of a high-dose concentrate of n-3 fatty acids or corn oil introduced early after an acute myocardial infarction on serum triacylglycerol and HDL cholesterol. (ekstern lenke)
• T. Omland; V. V. S. Bonarjee; Dennis W.T. Nilsen et al. (1993). Prognostic significance of N-terminal pro-atrial natriuretic factor (1-98) in acute myocardial infarction: comparison with atrial natriuretic factor (99-126) and clinical evaluation. (ekstern lenke)
• Reidun Aarsetøy; Hildegunn Aarsetøy; Tor-Arne Hagve et al. (2018). Initial Phase NT-proBNP, but Not Copeptin and High-Sensitivity Cardiac Troponin-T Yielded Diagnostic and Prognostic Information in Addition to Clinical Assessment of Out-of-Hospital Cardiac Arrest Patients With Documented Ventricular Fibrillation. (ekstern lenke)
• Peder Langeland Myhre; Are Kalstad; Sjur Hansen Tveit et al. (2022). Changes in eicosapentaenoic acid and docosahexaenoic acid and risk of cardiovascular events and atrial fibrillation: A secondary analysis of the OMEMI trial. (ekstern lenke)
• O Bleie; Øyvind Bleie; Anne Grete Semb et al. (2007). Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease. (ekstern lenke)
• Hui Zuo; Gard Frodahl Tveitevåg Svingen; Grethe S. Tell et al. (2018). Plasma concentrations and dietary intakes of choline and betaine in association with atrial fibrillation risk: Results from 3 prospective cohorts with different health profiles. (ekstern lenke)
• R Clarke; J. Armitage; S. Lewington et al. (2006). Homocysteine-lowering trials for prevention of cardiovascular events: A review of the design and power of the large randomized trials. (ekstern lenke)
• V. Tuseth; Ø. Hegland; L. Fjetland et al. (2001). Reversed flow in internal mammary artery conduit and vertebral artery with left subclavian artery occlusion causing angina and vertigo. The coronary – subclavian steal syndrome. (ekstern lenke)
• Dennis WT Nilsen; Ricardo Leon de la Fuente; P. Gallo et al. (2025). High admission levels of interleukin-1 receptor antagonist in acute myocardial infarction patients are associated with increased rates of all-cause mortality and cardiac death at five years follow-up. (ekstern lenke)
• Heidi Grundt; Dennis W.T. Nilsen; Ø. Hetland et al. (2004). Clinical outcome and atherothrombogenic risk profile after prolonged wash-out following long-term treatment with high doses of n-3 PUFAs in patients with an acute myocardial infarction. (ekstern lenke)
• Patrycja Næsgaard; Ricardo Leon de la Fuente; Stein Tore Nilsen et al. (2016). Suggested Cut-Off Values for Vitamin D as a Risk Marker for Total and Cardiac Death in Patients with Suspected Acute Coronary Syndrome.. (ekstern lenke)
• Eirik Magnus Meek Degerud; Rune Hoff; Ottar Nygård et al. (2015). Cosinor modelling of seasonal variation in 25-hydroxyvitamin D concentrations in cardiovascular patients in Norway. (ekstern lenke)
• Heidi Grundt; Dennis W.T. Nilsen; O Hetland et al. (1999). Atherothrombogenic risk modulation by n-3 fatty acids was not associated with changes in homocysteine in subjects with combined hyperlipidaemia. (ekstern lenke)
• Hildegunn Aarsetøy; E Valente; A Reine et al. (2008). Holotranscobalamin and methylmalonic acid as prognostic markers following an acute myocardial infarction. (ekstern lenke)
• Trygve Brügger-Andersen; Volker Pönitz; Frederic Kontny et al. (2009). The long pentraxin 3 (PTX3): a novel prognostic inflammatory marker for mortality in acute chest pain. (ekstern lenke)
• Hildegunn Aarsetøy; Volker Pönitz; Heidi Grundt et al. (2009). (n-3) Fatty Acid Content of Red Blood Cells Does Not Predict Risk of Future Cardiovascular Events following an Acute Coronary Syndrome. (ekstern lenke)
• Alf Inge Larsen; Åshild Hjørnevik; Vernon V.S Bonarjee et al. (2010). Coronary blood flow and perfusion pressure during coronary angiography in patients with ongoing mechanical chest compression: a report on 6 cases. (ekstern lenke)
• Volker Pönitz; Trygve Brügger-Andersen; David Pritchard et al. (2008). Activated Factor XII Type A Predicts Long-Term Mortality in Patients Admitted with Chest Pain. (ekstern lenke)
• Volker Pönitz; David Pritchard; Heidi Grundt et al. (2006). Specific types of activated Factor XII increase following thrombolytic therapy with tenecteplase. (ekstern lenke)
• Patrycja Næsgaard; Volker Pønitz; Hildegunn Aarsetøy et al. (2015). Prognostic utility of vitamin D in acute coronary syndrome patients in coastal Norway. (ekstern lenke)
• Øistein Rønneberg Mjelva; Trygve Brugger Andersen; Volker Pønitz et al. (2013). Long-term prognostic utility of PAPP-A and calprotectin in suspected acute coronary syndrome. (ekstern lenke)
• Y Rozenmann; Roxana Mehran; Bernard Witzenbichler et al. (2013). Relationship between the intensity of heparin anticoagulation and clinical outcomes in patients receiving glycoprotein IIb/IIIa inhibitors during primary percutaneous coronary intervention in acute myocardial infarction. (ekstern lenke)
• Øistein Mjelva; Volker Pønitz; Trygve Brugger Andersen et al. (2016). Long-term prognostic utility of pentraxin 3 and D-dimer as compared to high-sensitivity C-reactive protein and B-type natriuretic peptide in suspected acute coronary syndrome. (ekstern lenke)
• D. W. T. Nilsen; L. Gøransson; A.-I. Larsen et al. (1977). Systemic thrombin generation and activity resistant to low molecular weight heparin administered prior to streptokinase in patients with acute myocardial infarction. (ekstern lenke)
• Gard Frodahl Tveitevåg Svingen; Hui Zuo; Per Magne Ueland et al. (2018). Increased plasma trimethylamine-N-oxide is associated with incident atrial fibrillation. (ekstern lenke)
• Reidun Aarsetøy; Thor Ueland; Pål Aukrust et al. (2021). Angiopoietin-2 and angiopoietin-like 4 protein provide prognostic information in patients with suspected acute coronary syndrome. (ekstern lenke)
• Thomas Andersen; Thor Ueland; Pål Aukrust et al. (2022). Podocan and Adverse Clinical Outcome in Patients Admitted With Suspected Acute Coronary Syndromes.. (ekstern lenke)
• Volker Pönitz; Trygve Brügger-Andersen; David Pritchard et al. (2009). Activated factor XII type A and B-type natriuretic peptide are complementary and incremental predictors of mortality in patients following admission with acute coronary syndrome. (ekstern lenke)
• Patrycja Næsgaard; Heidi Grundt; Arne Nordøy et al. (2017). Vitamin D Uptake in Patients Treated with a High-Dosed Purified Omega-3 Compound in a Randomized Clinical Trial Following an Acute Myocardial Infarction.. (ekstern lenke)
• Hildegunn Aarsetøy; Trygve Brügger-Andersen; Øyvind Hetland et al. (2006). Long term influence of regular intake of high dose n-3 fatty acids on CD40-ligand, pregnancy-associated plasma protein A and matrix metal loproteinase-9 following acute myocardial infarction. (ekstern lenke)
• Trygve Brügger-Andersen; Hildegunn Aarsetøy; Heidi Grundt et al. (2008). The long-term prognostic value of multiple biomarkers following a myocardial infarction. (ekstern lenke)
• Hildegunn Aarsetøy; Edward Valente; Andreas Reine et al. (2008). Holotranscobalamin and methylmalonic acid as prognostic markers following an acute myocardial infarction. (ekstern lenke)
• Dennis W.T. Nilsen; Roxana Mehran; Roland S Wu et al. (2013). Coronary Reperfusion and Clinical Outcomes After Thrombus Aspiration During Primary Percutaneous Coronary Intervention: Findings From the HORIZONS-AMI Trial. (ekstern lenke)
• Espen Øglænd Bjørnestad; Hilde Olset; Indu Dhar et al. (2020). Circulating trimethyllysine and risk of acute myocardial infarction in patients with suspected stable coronary heart disease. (ekstern lenke)
• Dennis WT Nilsen; Peder Langeland Myhre; Svein Solheim et al. (2023). Total Bilirubin Yields Prognostic Information Following a Myocardial Infarction in the Elderly. (ekstern lenke)
• Thomas Andersen; Thor Ueland; Pål Aukrust et al. (2023). Procollagen type 1 N-terminal propeptide is associated with adverse outcome in acute chest pain of suspected coronary origin. (ekstern lenke)
• M Ebbing; Kaare Harald Bønaa; E Arnesen et al. (2010). Combined analyses and extended follow-up of two randomized controlled homocysteine-lowering B-vitamin trials. (ekstern lenke)
• Hildegunn Aarsetøy; Volker Pönitz; Odd Bjarte Nilsen et al. (2008). Low levels of cellular omega-3 increase the risk of ventricular fibrillation during the acute ischaemic phase of a myocardial infarction. (ekstern lenke)
• Alf Inge Larsen; Stein Ørn; Ståle Barvik et al. (2007). Anomalies of the coronary arteries originating from the right sinus of Valsalva (1) Single coronary artery originating from the right sinus associated with fusion of the left and the non coronary cusp and atrophy of the left coronary ostium (2)Three separate coronary arteries originating from the right sinus of Valsalva. (ekstern lenke)
• Alf Inge Larsen; Tor Melberg; Vernon V.S Bonarjee et al. (2008). Change to a primary PCI program increases number of patients offered reperfusion therapy and significantly reduces mortality. A real life experience evaluating the initiation of a primary PCI service at a single center without on site heart surgery in Western Norway. (ekstern lenke)
• Marta Ebbing; Øyvind Bleie; O Bleie et al. (2008). Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography - A Randomized controlled trial. (ekstern lenke)
• Alf Inge Larsen; Dennis W.T. Nilsen; Jennifer Yu et al. (2013). Long-term prognosis of patients presenting with ST-segment elevation myocardial infarction with no significant coronary artery disease (from The HORIZONS-AMI Trial). (ekstern lenke)
• Øistein Mjelva; Gard Frodahl Tveitevåg Svingen; Eva Ringdal Pedersen et al. (2018). Fibrinogen and Neopterin Is Associated with Future Myocardial Infarction and Total Mortality in Patients with Stable Coronary Artery Disease. (ekstern lenke)
• Dennis WT Nilsen; Reidun Aarsetøy; Volker Pønitz et al. (2024). α1-Antichymotrypsin Complex (SERPINA3) Is an Independent Predictor of All-Cause but Not Cardiovascular Mortality in Patients Hospitalized for Chest Pain of Suspected Coronary Origin. (ekstern lenke)
• Dennis W.T. Nilsen; Michelle Røysland; Thor Ueland et al. (2022). The Effect of Protease-Activated Receptor-1 (PAR-1) Inhibition on Endothelial-Related Biomarkers in Patients with Coronary Artery Disease. (ekstern lenke)
• Dennis WT Nilsen; Reidun Aarsetøy; Volker Pønitz et al. (2024). Chemokine ligand 18 predicts all-cause mortality in patients hospitalized with chest pain of suspected coronary origin. (ekstern lenke)
• Eirik Degerud; Ottar Nygård; Stefan De Vogel et al. (2018). Plasma 25-hydroxyvitamin D and mortality in patients with suspected stable angina pectoris. (ekstern lenke)
• Dennis W.t. Nilsen; Grethe Albrektsen; K. Landmark et al. (2001). Beneficial changes in serum triacylglycerol and HDL-cholesterol by a high-dosed concentrate of n-3 fatty acids introduced early after an acute myocardial infarction did not improve prognosis compared to corn oil. (ekstern lenke)
• Patrycja Næsgaard; Ricardo León de la Fuente; Stein Tore Nilsen et al. (2013). Vitamin D predicts all-cause and cardiac mortality in females with suspected acute coronary syndrome: a comparison with brain natriuretic peptide and high-sensitivity C-reactive protein. (ekstern lenke)
• Alf Inge Larsen; Sigurd Lindal; Kate Myreng et al. (2013). Cardiac resynchronization therapy improves minute ventilation/carbon dioxide production slope and skeletal muscle capillary density without reversal of skeletal muscle pathology or inflammation. (ekstern lenke)
• Trygve Eftestøl; Jan Terje Kvaløy; Dennis W.T. Nilsen et al. (2012). Analysis of Intracardiac Electrogram Changes. (ekstern lenke)
• Per-Jostein Samuelsen; Anne Elise Eggen; Terje Steigen et al. (2021). Incidence and risk factors for major bleeding among patients undergoing percutaneous coronary intervention: Findings from the Norwegian Coronary Stent Trial (NORSTENT). (ekstern lenke)
• Mads Malm Svenningsson; Gard Frodahl Tveitevåg Svingen; Per Magne Ueland et al. (2025). Elevated plasma trimethyllysine is associated with incident atrial fibrillation. (ekstern lenke)
• Alf Inge Larsen; Åshild Hjørnevik; Christian Lycke Ellingsen et al. (2007). Cardiac arrest with continuous mechanical chest compression during percutaneous coronary intervention A report on the use of the LUCAS device. (ekstern lenke)
• Heidi Grundt; Dennis W T Nilsen; M A Mansoor et al. (2003). Increased lipid peroxidation during long-term intervention with high doses of n-3 fatty acids (PUFAs) following an acute myocardial infarction. (ekstern lenke)
• Heidi Grundt; Ø. Hetland; Dennis W T Nilsen (2003). Changes in tissue factor and activated factor XII following an acute myocardial infarction were uninfluenced by high doses of n-3 polyunsaturated fatty acids. (ekstern lenke)
• Heidi Grundt; Dennis W T Nilsen; M A Mansoor et al. (2003). Reduction in homocysteine by n-3 polyunsaturated fatty acids after 1 year in a randomised double-blind study following an acute myocardial infarction: no effect on endothelial adhesion properties. (ekstern lenke)
• Reidun Aarsetøy; Torbjørn Omland; Helge Røsjø et al. (2020). N-terminal pro-B-type natriuretic peptide as a prognostic indicator for 30-day mortality following out-of-hospital cardiac arrest: A prospective observational study. (ekstern lenke)
• Dennis WT Nilsen; Hildegunn Aarsetøy; Volker Pønitz et al. (2025). Dihomo-gamma-linolenic acid (DGLA) is inversely related to risk for cardiac death and cardiovascular events during 2 years follow-up after admission for an acute coronary syndrome. (ekstern lenke)
• T Omland; Kenneth Dickstein; V Bonarjee et al. (2000). Plasma brain natriuretic peptide as a prognostic indicator in patients with preserved left ventricular systolic function after acute myocardial infarction. (ekstern lenke)
• EM Ohman; J Nanas; RJ Stomel et al. (2005). Thrombolysis and counterpulsation to improve survival in myocardial infarction complicated by hypotension and suspected cardiogenic shock or heart failure: results of the TACTICS Trial. (ekstern lenke)
• Øyvind Hetland; Anette Knudsen; Kenneth Dickstein et al. (2002). Characteristics and prognostic impact of plasma fibrin monomer (soluble fibrin) in patients with coronary artery disease. (ekstern lenke)
• Eva Ringdal Pedersen; Nora Tuseth; Simone Eussen et al. (2015). Associations of plasma kynurenines with risk of acute myocardial infarction in patients with stable angina pectoris. (ekstern lenke)
• Eirik Wilberg Rebnord; Eva Ringdal Pedersen; Elin Strand et al. (2015). Glycated hemoglobin and long-term prognosis in patients with suspected stable angina pectoris without diabetes mellitus: A prospective cohort study.. (ekstern lenke)
• H Grundt; DWT Nilsen; MA Mansoor et al. (2003). Reduction in homocysteine by n-3 polyunsaturated fatty acids after 1 year in a randomised double-blind study following acute myocardial infarction: no effect on endothelial adhesion proteins. (ekstern lenke)
• Volker Pönitz; José W. Govers-Riemslag; Hugo ten Cate et al. (2010). A history of late and very late stent thrombosis is not associated with increased activation of the contact system, a case control study. (ekstern lenke)
• Trygve Brügger-Andersen; Volker Pönitz; Harry Staines et al. (2008). The prognostic utility of D-dimer and fibrin monomer at long-term follow-up after hospitalization with coronary chest pain. (ekstern lenke)
• Dennis W.T. Nilsen; Øistein Mjelva; Ricardo Leon de la Fuente et al. (2015). Borderline values of troponin-T and high sensitivity C-reactive protein did not predict 2-year mortality inTnT positive chest-pain patients, whereas brain natriuretic peptide did. (ekstern lenke)
• Volker Pönitz; David Pritchard; Heidi Grundt et al. (2007). Changes of plasma activated Factor XII type A (XIIaA) concentrations following percutaneous coronary intervention (PCI). (ekstern lenke)
• Dennis WT Nilsen; Grethe Albrektsen; Knud Landmark et al. (2001). Effects of high-dose concentrate of n-3 fatty acids or corn oil introduced early after an acute myocardial infarction on serum triacylglycerol and HDL cholesterol. (ekstern lenke)
• Heidi Borgeraas; Elin Strand; Eva Kristine Ringdal Pedersen et al. (2012). Omega-3 status and the relationship between plasma asymmetric dimethylarginine and risk of myocardial infarction in patients with suspected coronary artery disease. (ekstern lenke)
• Marta Ebbing; Kaare Harald Bønaa; Ottar Nygård et al. (2009). Cancer incidence and mortality after treatment with folic acid and vitamin B12. (ekstern lenke)
• R Clarke; J. Armitage; S Lewington et al. (2006). Homocysteine-lowering trials for prevention of cardiovascular events: A review of the design and power of the large randomized trials. (ekstern lenke)
• Indu Dhar; Sumia Siddique; Eva Kristine Ringdal Pedersen et al. (2020). Lipid parameters and vitamin A modify cardiovascular risk prediction by plasma neopterin. (ekstern lenke)
• T. Omland; V. V. S. Bonarjee; Dennis W.T. Nilsen et al. (1993). Prognostic significance of N-terminal pro-atrial natriuretic factor (1-98) in acute myocardial infarction: comparison with artrial natriuretic factor (99-126) and clinical evaluation. (ekstern lenke)
• Ricardo León de la Fuente; Patrycja Næsgaard; Stein Tore Nilsen et al. (2013). Socioeconomic assessment and impact of social security on outcome in patients admitted with suspected coronary chest pain in the city of Salta, Argentina. (ekstern lenke)
• Alf Inge Larsen; Matthew I. Tomey; Roxana Mehran et al. (2014). Comparison of Outcomes in Patients with ST-Segment Elevation Myocardial Infarction Discharged on Versus Not on Statin Therapy (from the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction Trial). (ekstern lenke)
• Tor Melberg; Dennis W.T. Nilsen; Alf Inge Larsen et al. (2006). Nonemergent coronary angioplasty without on-site surgical backup: A randomized study evaluating outcomes in low-risk patients. (ekstern lenke)
• Ricardo León de la Fuente; Patrycja Næsgaard; Stein Tore Nilsen et al. (2012). Scand Cardiovasc J. 2012 Dec 12 [Epub ahead of print]. Omega-3 Index and prognosis in acute coronary chest pain patients with a low dietary intake of omega-3. (ekstern lenke)
• Hildegunn Aarsetøy; Reidun Aarsetøy; Thomas Werner Lindner et al. (2011). Low levels of the omega-3 index are associated with sudden cardiac arrest and remain stable in survivors in the subacute phase. (ekstern lenke)

Konferanseforedrag

• Dennis W.t. Nilsen (2001). Intra-aortic balloon pump therapy in cardiology – Stabilization and transport for surgery. (ekstern lenke)
• Marta Ebbing; Jan Erik Nordrehaug; Per M Ueland et al. (2007). WENBIT - Western Norway B-vitamin intervention trial. (ekstern lenke)
• Dennis W.T. Nilsen; Roland Wu; Jan Erik Nordrehaug et al. (2009). Impact of Thrombus Aspiration during Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction: Analysis from the HORIZONS-AMI Trial. AJC 2009; 104(6) Suppl.: p 3D (Abstract 7). (ekstern lenke)
• Volker Pönitz; Dennis W.T. Nilsen (2010). Activated Factor XII as a risk predictor for cardiovascular disease. (ekstern lenke)
• Dennis W T Nilsen; Grethe Albrektsen; K Landmark et al. (2000). A randomised study to evaluate the clinical efficacy of a high dosed concentrate of n-3 fatty acids introduced early after an acute myocardial infarction. (ekstern lenke)
• Bernard Witzenbichler; Giulio Guagliumi; Martin Desaga et al. (2008). Impact of diabetes mellitus on the safety and effectiveness of bivalirudin in patients with acute myocardial infarction undergoing primary angioplasty: The HORIZONS AMI trial. The SCAI Annual Scientific Sessions in Partnership with ACC i2 Summit, Chicago, March 29- April 1, 2008. Abstract 2900-192. (ekstern lenke)
• Volker Pønitz; David Pritchard; Trygve Brugger andersen et al. (2006). Changes In Activated Factor XII From Admission To Day 4 Strongly Predict Recurrent Troponin-T Positive Cardiac Events At 30 Days Following Admission For Myocardial InfarctionPathophysiol Haemos Thromb2006; 35:199-248. (ekstern lenke)
• Renske H Olie; Henri MH Spronk; Rene van Oerle et al. (2018). Effects of the PAR­1 receptor antagonist vorapaxar on platelet activation and coagulation biomarkers in patients with stable coronary artery disease. EHJ 2018;39(Suppl.)50. Abstract 355. (ekstern lenke)
• Dennis W.t. Nilsen; Heidi Grundt; Arne Nordøy (2002). Background diets rich in fish may mask the effect of high doses of n-3 fatty acids or corn oil introduced early after an acute myocardial infarction on clinical, despite an improvement in lipids. (ekstern lenke)
• Dennis W.T. Nilsen; Peder Langeland Myhre; Are Kalstad et al. (2021). Circulation 2021 (Nov. 8); 144 (Suppl. 1): A9147. Reduced delta-6-desaturase activity may be associated with major adverse cardiac events during 2 years follow up in elderly patients with a recent myocardial infarction.. (ekstern lenke)
• M Ohman; J Nanas; R Stomel et al. (2000). Trombolysis and counterpulsation to improve cardiogenic shock survival (TACTICS) Results of a prospective randomized trial. (ekstern lenke)
• Dennis W.T. Nilsen; Roland Wu; Alexandra J Lansky et al. (2009). Impact of Thrombus Aspiration in Patients with STEMI Undergoing Primary PCI: Analysis from the HORIZONS-AMI Trial. Circulation, Nov 2009; 120: S986. Abstract 4690. (ekstern lenke)
• Dennis W.T. Nilsen (2010). Hjerteforum 2010, 23 (2): 77-80. Antitrombotisk behandling ved akutt koronarsykdom. (ekstern lenke)
• Giulio Guagliumi; Bernard Witzenbichler; Jan Z. Peruga et al. (2008). Safety and effectiveness of bivalirudin compared to either abciximab or eptifibatide in patients with acute myocardial infarction undergoing primary angioplasty: The HORIZONS AMI trial. The SCAI Annual Scientific Sessions in Partnership with ACC i2 Summit. Chicago, March 29- April 1, 2008. Abstract 2900-28. (ekstern lenke)
• David Pritchard; Volker Pønitz; Trygve Brugger andersen et al. (2006). Activated Factor XII Type A Strongly Predicts All Cause Mortality after Hospitalisation with Chest Pain.AACC Annual Meeting, 2006, Chicago, Abstract nr. D52. (ekstern lenke)
• Trygve Brugger andersen; Volker Pønitz; Heidi Grundt et al. (2006). B-Type Natriuretic peptide is a predictor of all cause mortality at long-term follow-up after hospitalization with acute chest painEur Heart J 2006, 27(Abstract Suppl), 570. (ekstern lenke)
• Volker Pønitz; Heidi Grundt; Barbara Bottazzi et al. (2012). Circulation 2012;126:A13464(oral). Pentraxin 3 is Uninfluenced by High Doses of Concentrated Omega-3 Fatty Acids Administered for 12 Months Following an Acute Myocardial Infarction. (ekstern lenke)
• Patrycja Naesgaard; Volker Pønitz; Hildegunn Aarsetøy et al. (2013). Seasonal Discrepancy in the Correlation between Vitamin D and Omega-3 Index in Patients With Acute Coronary Syndrome from Western Norway. Circulation 2013; 128: A13208. (ekstern lenke)
• Trygve Eftestøl; Leik Woie; Kjersti Engan et al. (2012). Texture Analysis to Assess Risk of Serious Arrhythmias after Myocardial Infarction. (ekstern lenke)
• Volker Pønitz; Trygve Brugger andersen; David Pritchard et al. (2005). Activated factor XII provides better short-term prognostic information for a subsequent troponin-T positive event than other biomarkers in patients with myocardial infarction. J Thromb Haemost 2005;3:Suppl.1, OR155. ISSN:1740-3340. (ekstern lenke)
• Trygve Brugger andersen; Hildegunn Aarsetøy; Heidi Grundt et al. (2007). The prognostic value of NT-proBNP versus PAPP-A, MPO and CD40L following a myocardial infarction. European Heart Journal 2007;Vol.28 (Abstract Supplement):265: abstract 1699. (ekstern lenke)
• EM Ohman; J Nanas; R Stomel et al. (2000). A prospective randomized trial of thrombolysis and counterpulsation to improve cardiogenic shock survival: Preliminary results of the TACTICS trial. (ekstern lenke)
• Robert Clarke; J Halsey; S Lewington et al. (2010). Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals. (ekstern lenke)
• Reidun Aarsetøy; Thor Ueland; Pål Aukrust et al. (2020). Angiopoietin-2 is a long-term predictor of all-cause mortality, cardiac death and sudden cardiac death in chest-pain patients with suspected acute coronary syndrome.. (ekstern lenke)
• M Ohman; J Nanas; R Stomel et al. (2000). Trombolysis and counterpulsation to improve cardiogenic shock survival (TACTICS) Results of a prospective randomized trial. (ekstern lenke)
• Volker Pønitz; Trygve Brugger andersen; David Pritchard et al. (2006). Activated Factor XII type A strongly predicts all cause mortality after hospitalisation with TnT negative chest painEur Heart J 2006, 27(Abstract Suppl), 878. (ekstern lenke)
• Dennis WT Nilsen; Reidun Aarsetøy; Volker Pønitz et al. (2024). Circulation 2024; 150 (Suppl. 1): Abstract 4141048. Inflammatory biomarkers predict long-term all-cause mortality in males but not in females.. (ekstern lenke)
• Marta Ebbing; Øyvind Bleie; Jan Erik Nordrehaug et al. (2007). WENBIT -Western Norway B-vitamin Intervention Trial: P96, Clinical Chemistry & Laboratory Medicine. 45(5):A18, May 2007. (ekstern lenke)
• Volker Pønitz; Trygve Brugger andersen; David Pritchard et al. (2005). Activated factor XII type A strongly predicts all cause mortality after hospitalisation with TnT negative chest pain. Circulation 2005;112(17):Suppl.II:p388,abstract 1903. (ekstern lenke)
• Dennis W.t. Nilsen (2002). Lessons learned from the Stavanger Secondary Prevention Trial. (ekstern lenke)
• Pierluigi Tricoci; al. et; : Collaborator et al. (2012). Thrombin-receptor antagonist vorapaxar in acute coronary syndromes. Dennis W.T. Nilsen (primary investigator). N Engl J Med. 2012 Jan 5;366(1):20-33. doi: 10.1056/NEJMoa1109719. Epub 2011 Nov 13. (ekstern lenke)
• EM Ohman; J Nanas; R Stomel et al. (2000). A prospective randomized trial of thrombolysis and counterpulsation to improve cardiogenic shock survival: Preliminary results of the TACTICS trial. (ekstern lenke)
• David A Morrow; al. et; : Collaborator et al. (2012). Vorapaxar in the secondary prevention of atherothrombotic events. N Engl J Med. 2012 Apr 12;366(15):1404-13. doi: 10.1056/NEJMoa1200933. Epub 2012 Mar 24. Dennis W.T. Nilsen (National investigator). (ekstern lenke)
• Øistein Mjelva; Gard Frodahl Tveitevåg Svingen; Eva Ringdal Pedersen et al. (2015). Fibrinogen And Neopterin Predict Future Myocardial Infarction Events In Patients With Stable Coronary Heart Disease. Circulation. 2015;132:A19224.. (ekstern lenke)
• Patrycja Næsgaard; Volker Pønitz; Ricardo Leon de la Fuente et al. (2016). The Prognostic Utility of Vitamin D Across Continents in Patients with Suspected Acute Coronary Syndrome. Circulation. 2016; 133: AP028. (ekstern lenke)
• Volker Pönitz; Trygve Brügger-Andersen; Heidi Grundt et al. (2010). Circulation. 2010;122:A10837. Abstract 10837: Brain Natriuretic Peptide, but Not Calprotectin or the Long Pentraxin 3 Independently Predicts Stroke in Long-Term Follow-up of Patients With Acute Coronary Syndrome. (ekstern lenke)
• Patrycja Naesgaard; Ricardo León de la fuente; Patricio Gallo et al. (2011). Vitamin D Status is a 2-Year Predictor of All-Cause Mortality and Cardiac Death in Chest Pain Patients: A Prognostic Study from Salta, Northern-Argentina. Circulation 2011; 124(21): Supplement. Abstract 10377. (ekstern lenke)
• Marc P Bonaca; Benjamin M Scirica; Eugene Braunwald et al. (2012). Circulation 2012;126:A19144(oral). New Ischemic Stroke and Outcomes with Vorapaxar vs. Placebo: Results from TRA 2°P-TIMI 50 Trial. (ekstern lenke)
• Leik Woie; Line Wee; Hege Vefring et al. (2008). Identification of patients who benefit from implantable cardioverter defibrillators (ICD) by combining the genotypes for Angiotensinogen (AGT),Angiotensin-converting enzyme (ACE) and Angiotensin II type1 receptor (AT1R).Circulation 2008;118(12):e414-e491(Abstract O62, e427). (ekstern lenke)
• Dennis W.T. Nilsen; Michelle Røysland; Thor Ueland et al. (2022). Circulation 2022;146:A10315.The Effect of Protease-Activated Receptor-1 Inhibition With Vorapaxar in Post-mi and Nstemi Patients on Selected Biomarkers Reflecting Endothelial Function. (ekstern lenke)

Leserbrev

• Volker Pönitz; Jose W.P. Govers-Riemslag; Trygve Brügger-Andersen et al. (2009). Inhibitor complexes of the plasma kallikrein-kinin system and outcome prediction in patients following admission for chest pain. (ekstern lenke)
• Dennis WT Nilsen; Ricardo Leon de la Fuente; P. Gallo et al. (2025). Reply to: Reinterpreting interleukin-1 receptor antagonist elevation in acute myocardial infarction. (ekstern lenke)
• Dennis WT Nilsen; Ricardo Leon de la Fuente; P. Gallo et al. (2025). Reply to: Letter to the editor: High admission levels of interleukin-1 receptor antagonist in acute myocardial infarction patients. (ekstern lenke)
• Dennis W T Nilsen; W.S. Harris (2004). n-3 Fatty acids and cardiovascular disease. (ekstern lenke)
• Dennis WT Nilsen; Ricardo Leon de la Fuente; P. Gallo et al. (2025). Reply to: Could interleukin-1 receptor antagonist be a reliable predictor of prognosis in acute myocardial infarction?. (ekstern lenke)
• Dennis WT Nilsen; Ricardo Leon de la Fuente; Patricio Gallo et al. (2025). Reply to: Letter regarding the study by Nilsen et al. on IL-1RA and 5-Year Mortality Risk: Redefining the Threshold for high admission levels of IL-1RA - PubMed. (ekstern lenke)
• Dennis W.T. Nilsen; W.S. Harris (2004). n-3 Fatty acids and cardiovascular disease. (ekstern lenke)

Konferanseposter

• Hildegunn Aarsetøy; Edward Valente; Andreas Reine et al. (2006). No prognostic value of holo-transcobalamin or methylmalonic acid following an acute myocardial infarction.Circulation 2006; 113: e301-e381, abstrakt nummer P325. (ekstern lenke)
• Leik Woie; Trygve Eftestøl; Terje Jan Kvaløy et al. (2008). Intracardiac electrocardiographic (EGM) morphology changes in patients with implantable cardioverter defibrillator (ICD). Circulation, 2008;118(12):e162-e413 (Abstract P437, e238). (ekstern lenke)
• Frederic Kontny; Trygve Brügger-Andersen; Harry Staines et al. (2008). Long Pentraxin 3: A New, Independent Marker of Mortality in Acute Chest Pain. Circulation. 2008; 118(18): Suppl., Abstract 577. (ekstern lenke)
• Ottar Nygård; Elin Strand; Eva Kristine Ringdal Pedersen et al. (2012). Circulation 2012;126:A18411(poster). Dietary Intake of n-3 Long-Chain Polyunsaturated Fatty Acids, Diabetes Mellitus and Risk of Myocardial Infarction in Patients with Suspected Coronary Artery Disease. (ekstern lenke)
• Heidi Grundt; Øyvind Hetland; Anette Knudsen et al. (2002). Activated factor XII (FXIIa) predicts recurrent troponin-T positive cardiac events following an acute myocardial infarction. (ekstern lenke)
• Reidun Aarsetøy; Hildegunn Aarsetøy; Tor-Arne Hagve et al. (2016). Abstract 14067: Initial Phase NT-proBNP, but not Copeptin and High-Sensitivity Cardiac Troponin-T Yielded Valuable Information in Addition to Clinical Assessment of Out-of-Hospital Cardiac Arrest Patients. Circulation 2016;134 (Suppl.1): A14067. (ekstern lenke)
• Reidun Aarsetøy; Torbjørn Omland; Helge Røsjø et al. (2019). N-terminal Pro-B-Type Natriuretic Peptide may serve as a prognostic indicator for 30-day mortality following out-of-hospital cardiac arrest, whereas both high-sensitivity cardiac troponin-T and copeptin did not yield prognostic information. Circulation 2019; 140: Suppl 2, Abstract 135. (ekstern lenke)
• Reidun Aarsetøy; Hugo ten Cate; Henri M Spronk et al. (2019). Activated Factor IX-Antithrombin Complex predicts outcome after out-of-hospital cardiac arrest. Circulation 2019; 140: Suppl 2, Abstract 136. (ekstern lenke)
• Trygve Brügger-Andersen; Volker Pönitz; Frederic Kontny et al. (2009). The relationship between the long pentraxin 3 and B-type natriuretic peptide in patients admitted with acute coronary syndromes. European Heart Journal (2009)30 (Abstract Supplement),135. (ekstern lenke)
• Elin Strand; Mari Skar Manger; Marta Ebbing et al. (2009). Dietary intake of very long chain n-3 fatty acids and cardiovascular events in Norwegian patients with coronary artery disease: a cohort study. (ekstern lenke)
• Mohammad Azam Mansoor; Heidi Grundt; Arne Nordøy et al. (2003). Changes in plasma homocysteine and lipid peroxidation by n-3 polyunsaturated fatty acids administered to patients after an acute myocardial infarction. (ekstern lenke)
• M.A. Mansoor; Heidi Grundt; A. Nordøy et al. (2003). Changes in plasma homocysteine and lipid peroxidation by n-3 polyunsaturated fatty acids administered to patients after an acute myocardial infarction. (ekstern lenke)
• Dennis W.T. Nilsen; Peder Langeland Myhre; Are Kalstad et al. (2021). Circulation 2021 (Nov. 8); 144 (Suppl. 1): A9098. The relationship between linoleic acid (LA) and dihomo-gamma-linoleic acid (DGLA) as indicator of delta-6-desaturase activity... (ekstern lenke)
• Volker Pönitz; Trygve Brügger-Andersen; Øistein Mjelva et al. (2010). European Heart Journal 2010; 31 (Abstract Supplement): 803. P4661 : A combination of novel biomarkers for coagulation (XIIaA), vascular inflammation (PTX3) and heart failure (BNP) enhances prognostic information in patients admitted with chest pain. (ekstern lenke)
• Leik Woie; Trygve Eftestøl; Kjersti Engan et al. (2010). European Heart Journal 2010;Vol.31(Abstract Supplement):586. [2010] [P3371] Use of late gadolinium enhancement cardiovascular magnetic resonance images and texture analyses to distinguish patients with high and low risk of arrhythmias after myocardial infarction. (ekstern lenke)
• Thomas Andersen; Dennis W.T. Nilsen; Magnea Heidi Jonsdottir Grundt et al. (2021). Circulation 2021 (Nov. 8); 144 (Suppl. 1): A12013. Procollagen type-1 N-terminal propeptide, a collagen synthesis biomarker, is associated with adverse clinical outcome in patients with nsuspected acute coronary syndrome.. (ekstern lenke)
• Reidun Aarsetøy; Thor Ueland; Pål Aukrust et al. (2020). Angiopoietin-like 4 protein is a long-term predictor of outcome in chest-pain patients with suspected acute coronary syndrome. ESC 365 Library.. (ekstern lenke)
• H. Grundt; Øyvind Hetland; A. Knudsen et al. (2001). Influence of high-dosed n-3 fatty acids on coagulation markers after one year of treatment following an acute myocardial infarction. (ekstern lenke)
• Øyvind Hetland; Kenneth Dickstein; Dennis W.t. Nilsen (2001). Activation of coagulation in patients with acute chest pain syndromes as determined by fibrin monomer (soluble fibrin). (ekstern lenke)
• Ricardo León de la fuente; Patrycja Naesgaard; Stein Tore Nilsen et al. (2012). Circulation 2012;125(10)Suppl:AP069. Prognostic Impact of the Omega-3 Index in Chest Pain Patients With a Suspected Acute Coronary Syndrome and Low Dietary Intake of Omega-3. (ekstern lenke)
• Dennis W.T. Nilsen; Peder Langeland Myhre; Are Kalstad et al. (2021). Low levels of dihomo-gamma-linolenic acid are associated with all-cause death in elderly patients with a recent myocardial infarction.. (ekstern lenke)
• Øistein Mjelva; Volker Pønitz; Trygve Brugger Andersen et al. (2016). Global Heart, Vol. 11, Issue 2, e96–e97 Published in issue: June 2016 PM149 Activated End-Stage Coagulation (D-Dimer and Fibrin Monomer) but not Initial Stage (Fxiia) is Associated with the Burden of Thromboatheromatosis in Patients with Acute Coronary Syndrome. (ekstern lenke)
• T Omland; A Aakvaag; VVS Bonarjee et al. (2000). Plasma brain natriuretic peptide as a prognostic indicator in patients with preserved left ventricular systolic function after acute myocardial infarction. (ekstern lenke)
• Marta Ebbing; Kaare Harald Bønaa; Egil Arnesen et al. (2009). Kombinerte resultat og langtids oppfølging i NORVIT og WENBIT – to kliniske forsøk blant 6837 pasienter med iskemisk hjertesykdom. (ekstern lenke)
• L. Woie; Trygve Eftestøl; Jan Terje Kvaløy et al. (2008). Intracardiac electrocardiographic (EGM) morphology changes in patients with implantable cardioverter defibrillator (ICD). (ekstern lenke)
• Eva Ringdal Pedersen; Nora Tuseth; Simone Eussen et al. (2014). Associations of plasma kynurenines with risk of acute myocardial infarction in patients with stable angina pectoris. (ekstern lenke)
• Trygve Brugger Andersen; Volker Pønitz; David Pritchard et al. (2005). B-type Natriuretic Peptide is not only a predictor of death, but also of troponin-T positive cardiac events at long-term follow-up after hospitalization with acute chest pain. Circulation 2005; 112(17):Suppl.II:p 319, abstract 1600. (ekstern lenke)
• K Winckers; Volker Pönitz; Rene van Oerle et al. (2009). A retrospective case control study on the role of hypercoagulability in late stent thrombosis. Journal of Thrombosis and Haemostasis 2009; Volume 7, Supplement 2: Abstract PP-TH-344. (ekstern lenke)
• Øivind Midttun; Eva Kristine Ringdal Pedersen; Arve Ulvik et al. (2010). Inflammation suggest plasma concentration of 3-hydroxykynurenine as a metabolic marker of vitamin B6 status. (ekstern lenke)
• WH Ahmed; OA Mendiz; MR Thomas et al. (2011). Usage patterns and 1-year outcomes with the TAXUS Liberté stent: results of the TAXUS OLYMPIA registry. Catheter Cardiovasc Interv. 2011 Jun 1;77(7):979-92. doi: 10.1002/ccd.22805. Epub 2010 Dec 3. (ekstern lenke)
• Thomas Andersen; Dennis W.T. Nilsen; Magnea Heidi Jonsdottir Grundt et al. (2021). Circulation 2021 (Nov. 8); 144 (Suppl. 1): A9149. The novel Wnt-Pathway inhibitor podogan is not associated with all-cause mortality or cardiovascular outcome in patients admitted with suspected acute coronary syndrome.. (ekstern lenke)
• Trygve Brügger-Andersen; Hildegunn Aarsetøy; Heidi Grundt et al. (2009). Evaluation of plaque destabilization by pregnancy-associated plasma protein a (PAPPA) and coagulant activity did not predict reccurent Troponin-T positive cardiac events following an acute myocardial infarction. Journal of Thrombosis and Haemostasis 2009; Volume 7, Supplement 2: Abstract PP-WE-831. (ekstern lenke)
• Jose W.P. Govers-Riemslag; Volker Pönitz; Trygve Brügger-Andersen et al. (2009). Changes of inhibitory complexes of the plasma kallikrein-kinin system following percutaneous coronary intervention or thrombolytic therapy with tenecteplase. Journal of Thrombosis and Haemostasis 2009; Volume 7, Supplement 2: Abstract PP-WE-126. (ekstern lenke)
• Volker Pönitz; Jose W.P. Govers-Riemslag; Hugo ten Cate et al. (2009). A history of late stent thrombosis is not associated with increased activation of the contact phase system. Journal of Thrombosis and Haemostasis 2009; Volume 7, Supplement 2: Abstract PP-MO-433. (ekstern lenke)
• Volker Pönitz; Jose W.P. Govers-Riemslag; Jose Konings et al. (2009). The plasma kallikrein-kinin system and clinical outcome during follow-up in chest-pain-patients. Journal of Thrombosis and Haemostasis 2009; Volume 7, Supplement 2: Abstract PP-TH-131. (ekstern lenke)
• Elin Strand; Eirik Wilberg Rebnord; Eva Kristine Ringdal Pedersen et al. (2013). Hypoglycemia assessed by glycosylated haemoglobin (HbA1c) is related to risk of myocardial infarction in coronary artery disease patients without diabetes. EuroPRevent 2013; 2013-04-18 - 2013-04-21. (ekstern lenke)
• Trygve Brügger-Andersen; Volker Pönitz; Frederic Kontny et al. (2009). The value of calprotectin as a prognostic marker of cardiovascular risk in acute chest pain. European Heart Journal (2009)30(Abstract Supplement),472. (ekstern lenke)
• Hildegunn Aarsetøy; Volker Pønitz; Heidi Grundt et al. (2007). Omega-3 Index: A risk factor for ventricular fibrillation in the early post-myocardial inarction phase. 47th Annual Conference Cardiovascular disease Epidemiology and Prevention in association with the Council on Nutrition, Physical Activity, and Metabolism, Orlando, Florida. Circulation 2007; 115(8); e214-e301: e-237, Abstract P69. Print ISSN: 0009-7322. Online ISSN: 1524-4539. (ekstern lenke)
• Øyvind Hetland; H. Grundt; A. Knudsen et al. (2001). Triggering factors of coagulation (tissue factor and factor XIIa) in plasma of patients after acute myocardial infarction. (ekstern lenke)
• Dennis W.T. Nilsen; Kaare Harald Bønaa; Alf Inge Larsen et al. (2018). Circulation. 2018;138:A12525. No Effect of Glycoprotein Platelet Inhibitors Administered During Primary PCI in Patients Included in the Norwegian Coronary Stent Trial. (ekstern lenke)
• Øistein Mjelva; Volker Pønitz; Trygve Brugger Andersen et al. (2016). Global Heart, Vol. 11, Issue 2, e160. PT215 Novel Inflammatory Biomarkers Including Pentraxin-3 (PTX3), Pregnancy Associated Plasma Protein-A (PAPP-A) and Calprotectin were not Associated With the Burden of Thromboatheromatosis in Patients With Acute Coronary Syndrome. (ekstern lenke)
• Hildegunn Aarsetøy; Volker Pønitz; Heidi Grundt et al. (2006). No Protection of a High Omega-3 Index Following an Acute Myocardial Infarction.Atherosclerosis 2006; 7 (3): Suppl. pp 449. (ekstern lenke)
• Patrycja Naesgaard; Heidi Grundt; Cato Brede et al. (2014). The Effect on Vitamin D Levels of Long-term High-dose Treatment With a Concentrated Omega-3 Compound (Omacor®/Lovaza®) in Patients Hospitalized With a Myocardial Infarction. Core 2. Epidemiology and Prevention of CV Disease: Physiology, Pharmacology and LifestyleSession Title: Nutrition in CVD Risk and Prevention I. Circulation. 2014; 130: A17245. (ekstern lenke)
• Marta Ebbing; Øyvind Bleie; Jan Erik Nordrehaug et al. (2007). WENBIT - Western Norway B vitamin intervention trial. (ekstern lenke)
• Heidi Grundt; Dennis W.t. Nilsen; Øyvind Hetland (2002). Subacute effects of thrombolytic treatment on tissue factor, activated factor XII and fibrin monomer following an acute myocardial infarction. (ekstern lenke)
• Heidi Grundt; Dennis W.t. Nilsen; Øyvind Hetland (2002). Activity of the external coagulation pathway overruling the contact-phase system in coagulation activation following an acute myocardial infarction. (ekstern lenke)
• Øyvind Hetland; Trygve Brugger andersen; Volker Pønitz et al. (2005). Plasma concentrations of soluble fibrin, D-dimer, myeloperoxidase and pregnancy associated plasma protein A before and after treatment with PCI or thrombolysis for acute myocardial infarction. J Thromb Haemost 2005;3:Suppl.1, P 1696. ISSN: 1740-3340. (ekstern lenke)
• Trygve Brugger Andersen; Volker Pønitz; David Pritchard et al. (2005). B-Type Natriuretic peptide is not only a predictor of death, but also of troponin-T positive cardiac events at 6 months follow-up after hospitalisation with acute chest pain. Eur Heart J 2005;26 Abstract Supplement;717 (P4064). (ekstern lenke)
• Trygve Brügger-Andersen; Volker Pönitz; Harry Staines et al. (2009). The value of d-dimer and fibrin monomer as prognostic markers of death at 30 days follow-up in chest pain patients with suspected acute coronary syndrome. Journal of Thrombosis and Haemostasis 2009; Volume 7, Supplement 2: Abstract PP-WE-829. (ekstern lenke)
• Heidi Grundt; Dennis W T Nilsen; Ø. Hetland (2003). Tissue factor is a major determinant of thrombogenicity following an acute myocardial infarction. (ekstern lenke)
• Trygve Brugger Andersen; Volker Pønitz; Patrycja Naesgaard et al. (2011). D-dimer is an independent predictor of mortality at long-term follow-up in patients with suspected acute coronary syndrome. Journal of Thrombosis and Haemostasis 2011; 9: Supplement s2, P-TU-422. Article first published online: 31 JUL 2011. (ekstern lenke)
• Trygve Brugger Andersen; Volker Pønitz; Frederic Kontny et al. (2011). The long pentraxin 3 (PTX3), a biomarker of inflammation, predicts long-term mortality in patients hospitalized with suspected acute coronary syndrome. Journal of Thrombosis and Haemostasis 2011; 9, Issue Supplement s2, P-MO-556. Article first published online: 31 JUL 2011. (ekstern lenke)
• Trygve Brugger Andersen; Volker Pønitz; Frederic Kontny et al. (2011). The predictive value of the long pentraxin 3 (PTX3) for heart failure development in acute chest pain patients. Journal of Thrombosis and Haemostasis 2011; 9: Supplement s2, P-MO-567. Article first published online: 31 JUL 2011. (ekstern lenke)
• T Omland; A Aakvaag; VVS Bonarjee et al. (2000). Plasma brain natriuretic peptide as a prognostic indicator in patients with preserved left ventricular systolic function after acute myocardial infarction. (ekstern lenke)
• H. Grundt; Ø. Hetland; A. Knudsen et al. (2001). Influence on coagulation triggers of statins administered after an acute myocardial infarction. (ekstern lenke)
• H. Grundt; Dennis W.t. Nilsen; Ø. Hetland (2001). Coagulation markers as predictors of cardiovascular events following an acute myocardial infarction. (ekstern lenke)
• Volker Pønitz; Trygve Brugger andersen; David Pritchard et al. (2007). Activated factor XII type A is an independent predictor of all-cause mortality in patients admitted with chest pain. Arterioscl Thromb Vasc Biol 2007; 27; e35-e137: e128, P519. Print ISSN: 1079-5642. Online ISSN: 1524-4636. (ekstern lenke)
• Eirik Wilberg Rebnord; Eva Ringdal Pedersen; Elin Strand et al. (2014). GLYCOSYLATED HAEMOGLOBIN AND LONG-TERM PROGNOSIS IN PATIENTS WITH SUSPECTED STABLE ANGINA PECTORIS WITHOUT DIABETES. (ekstern lenke)
• Patrycja Naesgaard; Volker Pønitz; Trygve Brugger Andersen et al. (2012). Circulation 2012;125(10)Suppl:AP325. The Prognostic Utility of Vitamin D and Its Seasonal Variation in Chest Pain Patients with Suspected Acute Coronary Syndrome Recruited from a Coastal Population in Western-Norway. (ekstern lenke)
• Dennis WT Nilsen; Reidun Aarsetøy; Thor Ueland et al. (2023). Circulation 2023;148:A14503: Chemokine Ligand 18 (CCL18) is a Long-Term Predictor of All-Cause Mortality, but Did Not Predict CVD Events.. (ekstern lenke)
• Marta Ebbing; Kaare Harald Bønaa; Jan Erik Nordrehaug et al. (2009). Combined results and long-term follow-up in NORVIT and WENBIT with 6837 coronary artery disease patients: Homocysteine-lowering B-vitamin treatment does not prevent major cardiovascular events. European Heart Journal 2009: 30 (Abstract Supplement), 184. P 1274. (ekstern lenke)
• Trygve Brügger-Andersen; Volker Pönitz; Frederic Kontny et al. (2008). The Prognostic Value of the Long Pentraxin 3 as Compared to B-Type Natriuretic Peptide and High-Sensitive C-Reactive Protein, and their Combination, as a Prognostic Marker of Mortality in Acute Chest Pain Patients. Circulation. 2008; 118(18): Suppl., Abstract 576. (ekstern lenke)
• Leik Woie; Øyvind Hetland; Terje Jan Kvaløy et al. (2008). Effect of cardiac arrest induced by cardioverter defibrillator (ICD) testing on ischemia modified albumin (IMA).Circulation. 2008; 118(12):e162-e413 (Abstract P435, e238). (ekstern lenke)
• Heidi Grundt; Øyvind Hetland; Anette Knudsen et al. (2002). Activated factor XII predicts future events in survivors of acute myocardial infarction. (ekstern lenke)
• K Winckers; Volker Pönitz; Rene van Oerle et al. (2009). A case control study on platelet response to antiplatelet therapy in survivors of late stent thrombosis. Journal of Thrombosis and Haemostasis 2009; Volume 7, Supplement 2: Abstract PP-WE-072. (ekstern lenke)
• Volker Pønitz; David Pritchard; Heidi Grundt et al. (2005). Changes in concentration of specific forms of activated factor XII are observed following thrombolytic therapy with tenecteplase. J Thromb Haemost 2005;3:Suppl.1,P1615.ISSN: 1740-3340. (ekstern lenke)
• Volker Pønitz; David Pritchard; Heidi Grundt et al. (2005). Specific forms of activated factor XII in citrated plasma increase following percutaneous coronary intervention (PCI). J Thromb Haemost 2005;3:Suppl.1, P1736. ISSN:1740-3340. (ekstern lenke)
• Trygve Brügger-Andersen; Volker Pönitz; Frederic Kontny et al. (2009). The correlation of the long pentraxin 3 (PTX3) to lipids in patients hospitalized with acute chest pain. European Heart Journal (2009)30(Abstract Supplement),374. (ekstern lenke)
• Reidun Aarsetøy; Thor Ueland; Pål Aukrust et al. (2020). Complement component-7 is a long-term predictor of all-cause mortality in chest-pain patients with suspected acute coronary syndrome. ESC 365 Library. (ekstern lenke)
• Volker Pønitz; Trygve Brugger Andersen; Heidi Grundt et al. (2011). Admission level of pregnancy-associated plasma protein a predicts long term mortality within 7 years follow up in patients admitted with suspected acute coronary syndrome. Journal of Thrombosis and Haemostasis 2011; 9: Supplement s2, P-WE-596. Article first published online: 31 JUL 2011. (ekstern lenke)
• Volker Pønitz; Trygve Brugger Andersen; Heidi Grundt et al. (2011). The long pentraxin 3 (PTX3), a biomarker of inflammation, predicts long-term mortality in patients hospitalized with suspected acute coronary syndrome. Journal of Thrombosis and Haemostasis 2011; 9: Supplement s2,P-WE-146. Article first published online: 31 JUL 2011. (ekstern lenke)
• T Melberg; Alf Inge Larsen; S Barvik et al. (2006). Primary PCI vs thrombolysis:An analysis of differences in outcome in a single centre without on site heart surgery in South-West Norway. Eur Heart J 2006, 27(Abstract Suppl), 315. (ekstern lenke)
• T Melberg; Dennis W.T. Nilsen; Alf Inge Larsen et al. (2006). Non-emergent coronary angioplasty without on-site surgical back-up: A randomized study evaluating outcomes in low-risk patients. Eur Heart J 2006, 27(Abstract Suppl), 517. (ekstern lenke)
• Heidi Grundt; Dennis W.T. Nilsen; Ø Hetland et al. (2000). Influence on inflammatory markers of high-dose n-3 fatty acids after one year of treatment following an acute myocardial infarction. (ekstern lenke)
• Trygve Brügger-Andersen; Hildegunn Aarsetøy; Heidi Grundt et al. (2009). Would the use of N-terminal pro-B-type natriuretic peptide as a prognostic marker have changed our clinical judgement? Journal of Thrombosis and Haemostasis 2009; Volume 7, Supplement 2: Abstract PP-WE-830. (ekstern lenke)
• Øyvind Bleie; Anne Grete Semb; Jan Erik Nordrehaug et al. (2004). Inflammatory Markers CD40L, IL-6, Neopterin and CRP are Not Influenced by Homocysteine Lowering Therapy in Patients with Coronary Artery Disease. (ekstern lenke)
• Volker Pønitz; Trygve Brugger andersen; David Pritchard et al. (2007). Activated factor XII type A independently predicts 12 month mortality in chest pain patients. J Thromb Haemost 2007; Abstract ISTH 07A1_P-W-009. (ekstern lenke)
• Trygve Brugger andersen; Hildegunn Aarsetøy; Heidi Grundt et al. (2007). NT-proBNP, and not TF, FM; PAPPA-A or CD40 Ligand, predicts recurrent troponin-T positive cardiac events following an acute myocardial infarction. J Thromb Haemost 2007; Abstract ISTH 07A1_P-M-585. (ekstern lenke)
• Volker Pønitz; Trygve Brugger andersen; David Pritchard et al. (2007). Changes in activated factor XII type A from admission to Day 4 predict recurrent troponin T positive cardiac events following admission for myocardial infarction. Arterioscl Thromb Vasc Biol 2007; 27; e35-e137: e80, P243. Print ISSN: 1079-5642. Online ISSN: 1524-4636. (ekstern lenke)
• Patrycja Naesgaard; Ricardo León de la fuente; Stein Tore Nilsen et al. (2012). Circulation 2012;125(10)Suppl:AP310. The Distribution of Total- and HDL Cholesterol and Triglycerides is Significantly Different across Quartiles of Vitamin D in Chest-Pain Patients with a Suspected Acute Coronary Syndrome. (ekstern lenke)
• Nigussie Bogale; Tor Harald Melberg; Mette Storebø Skadberg et al. (2019). Patients discharged on the same day following elective PCI report equal satisfaction using health related quality of life instruments as compared to usual care: results from a randomized trial. EHJ 2019; 40: Suppl. 1, P6527, ehz746.1117. (ekstern lenke)
• Dennis W.T. Nilsen; Hildegunn Aarsetøy; Volker Pønitz et al. (2017). Circulation 2017;136:A18301 The Prognostic Utility of Dihomo-gamma-linolenic Acid (dgla) in Patients With Acute Coronary Heart Disease. (ekstern lenke)
• Hildegunn Aarsetøy; Trygve Brugger andersen; Heidi Grundt et al. (2006). No effect of omega-3 versus corn oil intervention on Pregnancy-Associated Plasma Protein A (PAPP-A) and CD-40 Ligand following an acute myocardial infarction.Circulation 2006; 113: e301-e381, abstrakt nummer P315. (ekstern lenke)
• Hildegunn Aarsetøy; Volker Pønitz; Heidi Grundt et al. (2006). No protection against new cardiac events of a high Omega-3 Index in patients presenting with an acute coronary syndrome.Circulation 2006:114(18) (Suppl II): abstr 4176. (ekstern lenke)
• Øistein Mjelva; Trygve Brugger Andersen; Volker Pønitz et al. (2014). BNP, PTX3 AND D-DIMER ARE LONG-TERM PREDICTORS OF MORTALITY IN CHEST PAIN PATIENTS – BNP AND HSCRP ALSO PREDICTS MYOCARDIAL INFARCTION. Atherosclerosis 2014; 235: e84–e191 (Abstract e142). (ekstern lenke)
• Trygve Brugger Andersen; Volker Pønitz; Heidi Grundt et al. (2005). Low fibrin monomer (soluble fibrin)concentration predicts troponin-T positive cardiac event free survival at 30 days follow-up after hospitalization with acute chest pain. JACC 2005;45:Supplement A, Abstract 1068-109. (ekstern lenke)
• Heidi Grundt; Dennis W T Nilsen; M.A. Mansoor (2003). Changes in homocysteine and lipid peroxidation by n-3 polyunsaturated fatty acids (PUFAs) administered after an acute myocardial infarction. (ekstern lenke)
• Heidi Grundt; Dennis W.t. Nilsen; Mohammad Azam Mansoor (2003). Changes in homocysteine and lipid peroxidation by n-3 polyunsaturated fatty acids (PUFAs) administered after an acute myocardial infarction. (ekstern lenke)
• Heidi Grundt; Dennis W.t. Nilsen; Øyvind Hetland (2003). Tissue factor is a major determinant of thrombogenicity following an acute myocardial infarction. (ekstern lenke)
• Hildegunn Aarsetøy; Volker Pønitz; Heidi Grundt et al. (2007). Cardiac omega-3 content and risk of future cardiovascular events following an acute coronary syndrome. European Heart Journal 2007;Vol.28 (Abstract Supplement):265: P3561. (ekstern lenke)
• Volker Pønitz; Trygve Brugger andersen; David Pritchard et al. (2007). Activated Factor XII Type A predicts cardiovascular outcome in patients admitted with chest pain. European Heart Journal 2007;Vol.28 (Abstract Supplement):113. (ekstern lenke)
• Alf Inge Larsen; Dennis W.T. Nilsen; Eugenia Nikolsky et al. (2010). Patients admitted with ST-segment elevation myocardial Infarction and a normal or near normal coronary angiogram have a favorable prognosis: Analysis from HORIZONS-AMI trial. J Am Coll Cardiol 2010;55;A187.E1746 doi:10.1016/S0735-1097(10)61747-0. (ekstern lenke)
• Elin Strand; Thomas Olsen; Eva Ringdal Pedersen et al. (2014). Serum acylcarnitines and risk of acute myocardial infarction and cardiovascular death in patients with stable angina pectoris. (ekstern lenke)
• Dennis WT Nilsen; Volker Pønitz; Reidun Aarsetøy et al. (2023). Circulation 2023; 148: Suppl_17 (Nov.). Abstract 14288. α1-Antichymotrypsin Complex (SERPINA3) is an Independent Predictor of Long-Term All-Cause Mortality, but Did Not Predict CVD Events. (ekstern lenke)
• Frederic Kontny; Ståle Barvik; Vernon V S Bonarjee et al. (2016). Global Heart, Vol. 11, Issue 2, e147 Published in issue: June 2016 PT129 Effects of Vorapaxar on Inflammatory Biomarkers in Patients With Stable Coronary Artery Disease. (ekstern lenke)
• Frederic Kontny; Ståle Barvik; Vernon V S Bonarjee et al. (2016). Global Heart, Vol. 11, Issue 2, e96 Published in issue: June 2016 PM146 Effects of the PAR-1 Receptor Antagonist Vorapaxar on Pentraxin 3 (PTX3) in Patients With an Acute Coronary Syndrome. (ekstern lenke)
• Trygve Eftestøl; Jan Terje Kvaløy; Dennis W.T. Nilsen et al. (2012). Analysis of Intracardiac Electrogram Changes. (ekstern lenke)
• Marta Ebbing; Kaare Harald Bønaa; Jan Erik Nordrehaug et al. (2009). Combined results and long-term follow-up in NORVIT and WENBIT with 6837 coronary artery disease patients: Homocysteine-lowering B-vitamin treatment does not prevent major cardiovascular events. (ekstern lenke)

Konferanseabstrakt

• L. Woie; Trygve Eftestøl; Terje Jan Kvaløy et al. (2008). Intracardiac electrocardiographic (EGM) morphology changes in patients with implantable cardioverter defibrillator (ICD). (ekstern lenke)
• DWT Nilsen; Roland Wu; Jan Erik Nordrehaug et al. (2009). Impact of Thrombus Aspiration during Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction: Analysis from the HORIZONS-AMI Trial. (ekstern lenke)
• Leik Woie; T Eftestoel; K Engan et al. (2010). Use of late gadolinium enhancement cardiovascular magnetic resonance images and texture analyses to distinguish patients with high and low risk of arrhythmias after myocardial infarction. (ekstern lenke)
• Gard Frodal Svingen; E R Pedersen; Per Magne Ueland et al. (2012). Plasma dimethylglycine is an independent risk factor of acute myocardial infarction in patients with stable angina pectoris. (ekstern lenke)
• Gregg W Stone et. al.; Dennis W.T. Nilsen; Jan Erik Nordrehaug (2009). Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction. N Engl J Med. 2009 May 7;360(19):1946-59. (ekstern lenke)
• Ricardo Leon de la Fuente; Hildegunn Aarsetøy; Trygve Brügger-Andersen et al. (2008). The relationship between BNP and hsCRP and quartiles of the omega-3 index in a beef eating ACS population in Argentina as compared to a coastal ACS population in Norway. (ekstern lenke)
• Dennis WT Nilsen; Patrycja Næsgaard; Volker Pønitz et al. (2025). ESC 365 - C-X-C motif chemokine ligand 5 (CXCL5) is associated with risk of all-cause mortality in a U-shaped manner in patients admitted with chest pain of suspected coronary origin.. (ekstern lenke)
• L. Woie; L. Wee; Hege Vefring et al. (2008). Identification of patients who benefit from implantable cardioverter defibrillators (ICD) by combining the genotypes for Angiotensinogen (AGT), Angiotensin-converting enzyme (ACE) and Angiotensin II type1 receptor (AT1R). (ekstern lenke)
• Hildegunn Aarsetøy; E Valente; A Reine et al. (2006). No prognostic value of holo-transcobalamin or methylmalonic acid following an acute myocardial infarction. (ekstern lenke)
• V. Poenitz; T Bruegger-Andersen; Heidi Grundt et al. (2012). Activated factor XII type A independently predicts outcome during seven years follow-up in patients admitted with suspected acute coronary syndrome. (ekstern lenke)
• David Morrow et al.; Dennis W.T. Nilsen; Lars Thomassen (2009). Evaluation of a novel antiplatelet agent for secondary prevention in patients with a history of atherosclerotic disease: design and rationale for the Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2 degrees P)-TIMI 50 trial. Am Heart J. 2009 Sep;158(3):335-341.e3. (ekstern lenke)
• Roxana Mehran et al.; Dennis W.T. Nilsen; Jan Erik Nordrehaug (2009). Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial. Lancet. 2009 Oct 3;374(9696):1149-59. Epub 2009 Aug 28. (ekstern lenke)
• Volker Pønitz; T Bruegger-Andersen; O Mjelva et al. (2010). A combination of novel biomarkers for coagulation (XIIaA), vascular inflammation (PTX3) and heart failure (BNP) enhances prognostic information in patients admitted with chest pain. (ekstern lenke)
• Trygve Brügger-Andersen; V. Pönitz; H Staines et al. (2012). BNP, PTX3, and D-dimer are predictors of death, but only BNP is also a predictor of troponin-T positive cardiac events at long-term follow-up after hospitalization with acute chest pain. (ekstern lenke)
• Dennis WT Nilsen; Ricardo Leon de la Fuente; Patrycja Næsgaard et al. (2025). ESC 365 - High admission levels of Interleukin-1 receptor antagonist (IL-1RA) in acute MI patients are associated with increased rates of all-cause mortality and cardiac death at 5 years follow-up.. (ekstern lenke)
• Volker Ponitz; Heidi Grundt; Barbara Bottazzi et al. (2013). THE LONG PENTRAXIN 3 DID NOT PREDICT OUTCOME WITHIN 45 MONTHS FOLLOW-UP IN PATIENTS FOLLOWING A SEVERE MYOCARDIAL INFARCTION. (ekstern lenke)
• Elin Strand; Mari Skar Manger; Marta Ebbing et al. (2009). Dietary intake of very long chain n-3 fatty acids and cardiovascular events in Norwegian patients with coronary artery disease: a cohort study. (ekstern lenke)
• Volker Pønitz; D. Pritchard; Heidi Grundt et al. (2004). Activated factor XII predicts troponin-T positive cardiac events at 30 days follow-up after hospitalization with acute chest pain. (ekstern lenke)
• Ricardo Leon de la Fuente; Hildegunn Aarsetøy; Sven Kiserud et al. (2008). Comparison of the omega-3 index in the acute coronary syndromes in a beef-eating population in Argentina as compared to a fish-eating population in Norway. (ekstern lenke)
• Volker Pønitz; Trygve Brugger Andersen; Heidi Grundt et al. (2012). Long Pentraxin 3 (PTX3), Activated Factor XII type A (XIIaA) and B-type Natriuretic Peptide (BNP) did not independently predict stroke during seven years follow-up in patients admitted with chest pain. (ekstern lenke)
• Hall Schartum-Hansen; Eva Kristine Ringdal Pedersen; Gard Frodal Svingen et al. (2012). Relationship between plasma choline and betaine levels and risk of acute myocardial infarction in patients with stable coronary heart disease. (ekstern lenke)
• Trygve Brügger-Andersen; Volker Pönitz; Heidi Grundt et al. (2005). B-Type Natriuretic peptide is not only a predictor of death, but also of troponin-T positive cardiac events at 6 months follow-up after hospitalisation with acute chest pain. (ekstern lenke)
• Volker Pönitz; Trygve Brügger-Andersen; David Pritchard et al. (2008). Activated Factor XII and B-type natriuretic peptide, but not C-reactive protein, are independent predictors of mortality following admission with suspected myocardial infarction. (ekstern lenke)
• Ricardo Leon de la Fuente; Hildegunn Aarsetøy; Pietro Gallo et al. (2008). The relationship between serum lipids and quartiles of the omega-3 index in a beef eating population in Argentina as compared to a fish eating ACS population in Norway. (ekstern lenke)
• Ricardo Leon de la Fuente; Pietro Gallo; Silvia A. Dib Ashur et al. (2008). Serum triglycerides may reflect the content of cellular omega-3 fatty acids in CHD populations with a low intake of fish. (ekstern lenke)
• Volker Pönitz; Trygve Brügger-Andersen; David Pritchard et al. (2008). Activated Factor XII type A is an independent predictor of cardiovascular outcome in coronary patients admitted with troponin T negative chest pain. (ekstern lenke)

Lederartikkel

• Dennis WT Nilsen (2023). Prognostic Potential of Total Bilirubin in Secondary CVD Prevention. (ekstern lenke)
• Hugo ten Cate; Frederic Kontny; Dennis W.T. Nilsen (2019). Editorial: Novel and potential markers for prediction of outcome in patients with acute and chronic coronary heart disease.. (ekstern lenke)
• Dennis WT Nilsen; Frederic Kontny; Hugo Ten Cate (2024). Editorial: Novel and potential biomarkers for prediction of outcome in patients with chronic and acute coronary heart disease, volume II. (ekstern lenke)
• Dennis W.T. Nilsen (2013). Potential Benefits of Ticagrelor beyond Platelet Inhibition. (ekstern lenke)
• Heidi Grundt; Dennis W.T. Nilsen (2008). n-3 fatty acids and cardiovascular disease. (ekstern lenke)

Vitenskapelig litteraturgjennomgang

• Hildegunn Aarsetøy; Heidi Grundt; Ottar Nygård et al. (2012). The Role of Long-Chained Marine N-3 Polyunsaturated Fatty Acids in Cardiovascular Disease. (ekstern lenke)

Doktorgradsavhandling

• Dennis W.T. Nilsen; Patrycja Næsgaard (2016). Prognostic impact of vitamin D in coronary chest pain populations with high and low dietary intake of omega-3; comparison of a subtropical and a Nordic population. (ekstern lenke)
• Reidun Aarsetøy; Dennis W.T. Nilsen (2022). Biomarkers related to outcome in patients with out-of-hospital cardiac arrest and in hospitalized patients with clinically suspected acute coronary syndrome.. (ekstern lenke)
• Tor Melberg; Jan Erik Nordrehaug; Dennis W.T. Nilsen (2010). The initiation and evaluation of a percutaneous coronary intervention program at a hospital without on-site cardial surgery in Western Norway. (ekstern lenke)
• Heidi Grundt; Dennis W.T. Nilsen (2004). Risk evaluation in atherothrombogenic populations receiving a high dose of n-3 fatty acids, with special reference to homocysteine, tissue factor, activated factor XII and peroxidation. (ekstern lenke)
• Øistein Mjelva; Dennis W.T. Nilsen; Ottar Nygård (2017). Cardiovascular biomarkers as prognostic indicators in coronary chest pain patients. (ekstern lenke)
• Hildegunn Aarsetøy; Dennis W.T. Nilsen (2010). N-3 fatty acids in relation to risk markers and clinical outcome in the acute coronary syndrome. (ekstern lenke)
• Thomas Andersen; Frederic Kontny; Magnea Heidi Jonsdottir Grundt et al. (2025). Novel biomarkers for risk prediction in chest pain and acute coronary syndromes. (ekstern lenke)
• Ricardo Leon de la Fuente; Dennis W.T. Nilsen (2013). Prognostic indicators of total-, cardiac- and sudden cardiac death in chest pain patients with suspected acute coronary syndrome (ACS); with special reference to socioeconomic class, B-type natriuretic peptide (BNP), high sensitivity C-reactive protein(hsCRP), vitamin D and the omega-3 index, https://bora.uib.no/handle/1956/6726. (ekstern lenke)
• Trygve Brügger-Andersen; Dennis W.T. Nilsen (2009). Biomarkers for global risk assessment in the acute coronary syndrome. Dissertation for the degree of philosophiae doctor (Ph.D), University of Bergen, Norway, 27.11.2009. (ekstern lenke)
• Volker Pönitz; Dennis W.T. Nilsen (2009). Studies on risk prediction in patients with chest pain and associations of the contact system to coronary heart disease, with reference to specific forms of activated Factor XII. Dissertation for the degree of philosophiae doctor (Ph.D), Institute of Medicine, Faculty of Medicine, University of Bergen, Norway, 06.11.2009. (ekstern lenke)

Fremhevet artikkel i media

• Robert Clarke; J. Armitage; S. Lewington et al. (2007). Homocysteine-lowerng trials for prevention of vascular disease: protocol for a collaborative meta-analysis. (ekstern lenke)

Populærvitenskapelig artikkel

• Dennis W.T. Nilsen; Patrycja Næsgaard; Ricardo Leon de la Fuente (2012). BestPractice. Hjerte-karsykdommer 2012;2(4):20-24. Betydningsfulle prognosemarkører hos pasienter med koronarsuspekte brystsmerter. (ekstern lenke)

Forelesning

• Dennis WT Nilsen; Trygve Brugger Andersen; Reidun Aarsetøy et al. (2024). Circulation 2024; 150(Suppl. 1):Abstract 4137965. Volume 150, Number Suppl_1D-dimer as a 5-year predictor of death in females admitted with chestpain of suspected coronary origin surpasses that of males.. (ekstern lenke)

Se en full oversikt over publikasjoner i Cristin